Phase 3 Readout
WST: Phase 3 Topline: A Phase III, Long-Term, Randomized, Double-blind, Placebo-controlled Trial of Troriluzole in Adult P
August 1, 2026 · troriluzole. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- August 1, 2026
- Company
- West Pharmaceutical Services Inc. (WST)
- Drug
- troriluzole
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 3 Readout~month
Phase 3 Topline: A Phase III, Long-Term, Randomized, Double-blind, Placebo-controlled Trial of Troriluzole in Adult P
- Drug
- troriluzole
- Indication
- Spinocerebellar Ataxia Type 2; Spinocerebellar Ataxia Type 7; Spinocerebellar Ataxia Type 8